A detailed history of Perbak Capital Partners LLP transactions in Cigna Corp stock. As of the latest transaction made, Perbak Capital Partners LLP holds 1,432 shares of CI stock, worth $388,544. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,432
Previous 4,761 69.92%
Holding current value
$388,544
Previous $1.57 Billion 73.77%
% of portfolio
0.07%
Previous 0.36%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$262.23 - $334.39 $872,963 - $1.11 Million
-3,329 Reduced 69.92%
1,432 $413 Million
Q2 2025

Aug 14, 2025

BUY
$301.89 - $340.04 $1.44 Million - $1.62 Million
4,761 New
4,761 $1.57 Billion
Q4 2024

Feb 14, 2025

SELL
$265.59 - $358.58 $2.2 Million - $2.97 Million
-8,289 Reduced 80.16%
2,051 $566 Million
Q3 2024

Nov 14, 2024

BUY
$319.12 - $367.1 $1.57 Million - $1.81 Million
4,931 Added 91.16%
10,340 $3.58 Billion
Q2 2024

Aug 14, 2024

BUY
$330.57 - $364.08 $1.79 Million - $1.97 Million
5,409 New
5,409 $1.79 Billion

Others Institutions Holding CI

About Cigna Corp


  • Ticker CI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 305,116,000
  • Market Cap $82.8B
  • Description
  • Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health c...
More about CI
Track This Portfolio

Track Perbak Capital Partners LLP Portfolio

Follow Perbak Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perbak Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Perbak Capital Partners LLP with notifications on news.